ITERUM THERAPEUTICS PLC (ITRM) Stock Balance Sheet
NASDAQ:ITRM - Nasdaq - IE000TTOOBX0 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.07M | 21.09M | 27.45M | 14.51M | 4.80M | |||
| Marketable Securities | 17.86M | 39.75M | 53.94M | 2.36M | 1.14M | |||
| Receivables | 38.00K | 400.00K | 370.00K | 60.00K | 80.00K | |||
| Other Current Assets | 1.63M | 1.21M | 1.52M | 4.54M | 5.71M | |||
| Total Current Assets | 25.60M | 62.44M | 83.27M | 21.47M | 11.72M | |||
| Non-Current Assets | ||||||||
| PPE Net | 600.00K | 1.84M | 3.83M | 5.68M | 7.72M | |||
| Intangibles | 0.00 | 1.72M | 3.44M | N/A | N/A | |||
| Other Non-Current Assets | 63.00K | 830.00K | 980.00K | 5.64M | 6.32M | |||
| Total Non-Current Assets | 663.00K | 4.39M | 8.24M | 11.32M | 14.03M | |||
| TOTAL ASSETS | 26.26M | 66.83M | 91.51M | 32.79M | 25.75M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 1.63M | 6.49M | 5.80M | |||
| Accrued Expenses | 8.13M | 4.68M | 1.63M | 2.40M | 13.04M | |||
| Accounts Payable | 5.00M | 2.77M | 880.00K | 820.00K | 15.49M | |||
| Other Current Liabilities | 396.00K | 1.61M | 8.81M | 31.99M | 2.66M | |||
| Total Current Liabilities | 13.52M | 9.06M | 12.94M | 41.70M | 36.99M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 18.96M | 28.47M | 24.90M | 35.85M | 7.63M | |||
| Other Non-Current Liabilities | 188.00K | 1.30M | 3.44M | 5.80M | 7.38M | |||
| Total Non-Current Liabilities | 19.14M | 29.77M | 28.34M | 41.65M | 15.00M | |||
| TOTAL LIABILITIES | 32.66M | 38.83M | 41.28M | 83.35M | 51.99M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -461.30M | -422.93M | -378.49M | -286.93M | -234.92M | |||
| Additional Paid In Capital | 454.76M | 451.15M | 426.90M | 235.88M | 208.54M | |||
| Common Shares | 135.00K | 130.00K | 1.83M | 490.00K | 150.00K | |||
| Other Shareholders' Equity | 1.00K | -350.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 13.50M | 12.60M | 12.19M | 3.30M | 990.00K | |||
| Tangible Book Value per Share | -0.47 | 2.09 | 3.84 | -15.32 | -26.51 | |||
| Total Shareholders' Equity | -6.40M | 28.00M | 50.23M | -50.56M | -26.24M | |||
| TOTAL LIABILITIES AND EQUITY | 26.26M | 66.83M | 91.51M | 32.79M | 25.75M | |||
| Statistics | ||||||||
| Debt/Equity | -2.96 | 1.02 | 0.50 | -0.71 | -0.29 | |||
| Current Ratio | 1.89 | 6.89 | 6.44 | 0.51 | 0.32 | |||
| Return On Assets (ROA) | -146.13% | -66.48% | -100.05% | -158.62% | -400.50% | |||
| Return On Equity (ROE) | N/A | -158.68% | -182.28% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21